Genmab A/S (GMAB)
27.66
-1.99
(-6.71%)
USD |
NASDAQ |
Mar 03, 16:00
27.66
0.00 (0.00%)
After-Hours: 20:00
Genmab Price : 27.66 for March 3, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 233.86 |
| Novo Nordisk A/S | 36.66 |
| Krystal Biotech, Inc. | 263.80 |
| Ascendis Pharma A/S | 239.22 |
| Zealand Pharma A/S | 57.00 |
Price Related Metrics
| PE Ratio | 17.87 |
| PS Ratio | 4.726 |
| Price to Book Value | 2.914 |
| Price to Free Cash Flow | 15.53 |
| Earnings Yield | 5.60% |
| Market Cap | 17.04B |
| Operating PE Ratio | 14.06 |
| Normalized PE Ratio | 15.89 |